Dopamine agonist monotherapy in Parkinson's disease and potential risk factors for dyskinesia: a meta-analysis of levodopa-controlled trials
Author:
Affiliation:
1. Department of Neurology; University of Ioannina; Ioannina Greece
2. Department of Internal Medicine; University of Ioannina; Ioannina Greece
3. Department of Neurology; Medical School; University of Dresden; Dresden Germany
Publisher
Wiley
Subject
Neurology (clinical),Neurology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.12318/fullpdf
Reference40 articles.
1. Levodopa-induced dyskinesias;Fabbrini;Mov Disord,2007
2. Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis;Baker;Parkinsonism Relat Disord,2009
3. Dopamine agonist therapy in early Parkinson's disease;Stowe;Cochrane Database Syst Rev,2008
4. Systematic review of levodopa dose equivalency reporting in Parkinson's disease;Tomlinson;Mov Disord,2010
5. Controlling the risk of spurious findings from meta-regression;Higgins;Stat Med,2004
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration;Neuropharmacology;2023-10
2. Dopamine agonists versus levodopa monotherapy in early Parkinson's disease for the potential risks of motor complications: A network meta-analysis;European Journal of Pharmacology;2023-09
3. Ropinirole Cotreatment Prevents Perivascular Glial Recruitment in a Rat Model of L-DOPA-Induced Dyskinesia;Cells;2023-07-14
4. The complex molecular pharmacology of the dopamine D2 receptor: Implications for pramipexole, ropinirole, and rotigotine;Pharmacology & Therapeutics;2023-05
5. The Comparative Efficacy of Non-ergot Dopamine Agonist and Potential Risk Factors for Motor Complications and Side Effects From NEDA Use in Early Parkinson's Disease: Evidence From Clinical Trials;Frontiers in Aging Neuroscience;2022-04-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3